Literature DB >> 30370104

More evidence for shortening antibiotic therapy in peritonitis: the DURAPOP trial.

Hira H Abidi1, Robert G Sawyer1.   

Abstract

Year:  2018        PMID： 30370104      PMCID： PMC6186626          DOI： 10.21037/jtd.2018.07.67

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Is very short-course antibiotic therapy possible in postoperative intra-abdominal infections? Discussion on "Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial".

Authors:  Alejandro Suarez-de-la-Rica; Fernando Gilsanz; Emilio Maseda; Philippe Montravers; Sigismond Lasocki; Thomas Lescot; Herve Dupont
Journal:  Intensive Care Med       Date:  2018-04-13       Impact factor: 17.440

2.  Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.

Authors:  Rishi Rattan; Casey J Allen; Robert G Sawyer; Reza Askari; Kaysie L Banton; Jeffrey A Claridge; Christine S Cocanour; Raul Coimbra; Charles H Cook; Joseph Cuschieri; E Patchen Dellinger; Therese M Duane; Heather L Evans; Pamela A Lipsett; John E Mazuski; Preston R Miller; Patrick J O'Neill; Ori D Rotstein; Nicholas Namias
Journal:  J Am Coll Surg       Date:  2016-01-14       Impact factor: 6.113

3.  Trial of short-course antimicrobial therapy for intraabdominal infection.

Authors:  Robert G Sawyer; Jeffrey A Claridge; Avery B Nathens; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Mark A Wilson; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Christopher M Watson; Raul Coimbra; Daniel L Dent; Stephen F Lowry; Christine S Cocanour; Michaela A West; Kaysie L Banton; William G Cheadle; Pamela A Lipsett; Christopher A Guidry; Kimberley Popovsky
Journal:  N Engl J Med       Date:  2015-05-21       Impact factor: 91.245

4.  Longer-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections.

Authors:  Taryn E Hassinger; Christopher A Guidry; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Raul Coimbra; Christine S Cocanour; Kaysie L Banton; Joseph Cuschieri; Kimberley Popovsky; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2017-06-26       Impact factor: 2.150

5.  Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.

Authors:  Philippe Montravers; Florence Tubach; Thomas Lescot; Benoit Veber; Marina Esposito-Farèse; Philippe Seguin; Catherine Paugam; Alain Lepape; Claude Meistelman; Joel Cousson; Antoine Tesniere; Gaetan Plantefeve; Gilles Blasco; Karim Asehnoune; Samir Jaber; Sigismond Lasocki; Herve Dupont
Journal:  Intensive Care Med       Date:  2018-02-26       Impact factor: 17.440

6.  Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

Authors:  Jean Chastre; Michel Wolff; Jean-Yves Fagon; Sylvie Chevret; Franck Thomas; Delphine Wermert; Eva Clementi; Jesus Gonzalez; Dominique Jusserand; Pierre Asfar; Dominique Perrin; Fabienne Fieux; Sylvie Aubas
Journal:  JAMA       Date:  2003-11-19       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.